Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2022-05-16 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
中源协和细胞基因工程股份有限公司2021年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2021 Annual General Meeting Resolution Announcement" and details the resolutions passed at the 2021 Annual General Meeting (AGM) held on May 16, 2022. It includes voting results on various agenda items such as the 2021 annual report, financial statements, profit distribution plan, and amendments to company rules. The document also confirms the legality and validity of the meeting and voting process, witnessed by lawyers. The content is focused on announcing the results and details of the AGM rather than presenting the full annual report or financial statements themselves. The document length is 3466 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2022-05-16 Chinese
中源协和细胞基因工程股份有限公司关于召开2021年度业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about the scheduling and details of a 2021 annual performance explanation meeting (业绩说明会) for investors. It references the 2021 annual report but does not contain the report itself or detailed financial data. The document provides information on the meeting time, location, participants, and how investors can engage. It is essentially an invitation and informational notice about the performance explanation meeting, which aligns with the definition of an Investor Presentation (IP) as it focuses on financials, strategy, and market position presented to investors. The document length is short (1251 characters), and it is not a full report or transcript but an announcement of the event. Therefore, the best classification is Investor Presentation (IP).
2022-05-10 Chinese
中源协和细胞基因工程股份有限公司关于召开2021年年度股东大会的提示性公告
AGM Information Classification · 95% confidence The document is a detailed announcement about the convening of the 2021 Annual General Meeting (AGM) of the company, including the date, voting methods, meeting agenda, and instructions for shareholders. It does not contain the actual annual report or financial statements but rather information about the meeting where such reports will be discussed and voted on. The document is relatively short (3519 characters) and serves as a notice or reminder for the AGM, not the report itself. Therefore, it fits the category of AGM Information (AGM-R).
2022-05-10 Chinese
中源协和细胞基因工程股份有限公司2021年年度股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as materials for the 2021 Annual General Meeting (AGM) of 中源协和细胞基因工程股份有限公司, dated May 16, 2022. It includes the meeting agenda, detailed reports such as the 2021 Board of Directors work report, Supervisory Board report, the full 2021 Annual Report and summary, and the 2021 financial final accounts report. The content is comprehensive, covering company performance, governance, financial results, and future plans, typical of AGM materials. The document is lengthy (15,000 characters) and contains detailed meeting materials rather than just an announcement or a brief summary. Therefore, it fits the category of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting.
2022-05-06 Chinese
中源协和细胞基因工程股份有限公司财务总监辞职公告
Board/Management Information Classification · 100% confidence The document is a resignation announcement of the company's financial director, detailing the departure and transition arrangements. It does not contain financial statements, audit information, or regulatory filings related to financial performance. It is an announcement related to senior management changes, specifically the resignation of a key executive. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on management change, confirming this classification.
2022-04-27 Chinese
中源协和细胞基因工程股份有限公司关于股东变更公司名称及其他工商登记信息的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding changes in shareholder company name and other business registration information. It explicitly states that there is no change in shareholding or control, and it is a formal notification of changes in corporate registration details. There is no financial data, no report attached or referenced, and no mention of board or management personnel changes. This fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2022-04-25 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.